Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$25,000.00
Jul 1, 2019
For-profit organization
Development of an Assay for Screening of Pathogenic Bacterial Strains
931407
The rhomboid protease gene glpG is essential for ExPEC E. coli colonization, which occurs naturally in the gut. However some strains can spread to other niches leading to pathologies: blood infections and urinary tract infections. The GlpG protease likely cleaves a protein(s) that regulates the production of protein(s) important for colonization. We are are trying to explore the role of glpG gene and its influence in bacterial colonization during health and disease. We will be also looking for physiological substrates for GlpG using biochemical assays. This assay can used for the detection of antibiotic resistant bacteria in hospitals and other areas as needed. We intend to commercialize the assay to pharmaceutical industry.